Research Article
Volume 8 Issue 2 - 2021
Combination of Intragastric Balloon and Liraglutide: Short-Term Results
Anna Carolina Hoff*, Barrichello SA, Galvão Neto M, Grecco E, Bezerra L and Nunes GC
Diagnostic and Therapeutic Digestive Endoscopy/Bariatric and Respiratory Endoscopy, Technical Director Angioskope SP/Vale, Brazil
*Corresponding Author: Anna Carolina Hoff, Diagnostic and Therapeutic Digestive Endoscopy/Bariatric and Respiratory Endoscopy, Technical Director Angioskope SP/Vale, Brazil.
Received: February 13, 2021; Published: February 26, 2021




Abstract

Introduction: As isolated therapies, intragastric balloon and liraglutide are used throughout the world to treat excess weight and obesity.

Objective: Compare the effectiveness of intragastric balloon therapy alone and combined with liraglutide.

Methods: Ninety patients (64 women) were randomly divided into two groups of 45 people with the same composition (32 women and 13 men). Group 1 underwent isolated therapy with an intragastric balloon (IGB) for a period of six months. Group 2 also received an IGB implant, along with a daily dose of liraglutide (maximum: 3.0 mg).

Results: Mean age was 34.4 years. Mean initial BMI was 33.93 kg/m2 in Group 1 and 33.95 kg/m2 in Group 2. Forty-two patients in Group 1 and 31 in Group 2 completed treatment. The mean reduction in BMI was significantly greater in Group 2 (7.23 ± 1.07) compared to Group 1 (6.21 ± 0.88) (p < 0.001). The same was found regarding percentage of total body weight loss (22.21 ± 2.94 in Group 2 vs. 18.29 ± 2.16 in Group 1), percentage of excess weight loss (86.53 ± 17.06 in Group 2 vs. 71.81 ± 14.50 in Group 1) and absolute weight loss in kg (21.71 ± 3.72 in Group 2 vs. 17.90 ± 2.87 in Group 1) (p < 0.001 for all comparisons).

Conclusion: Both treatments are effective at promoting weight loss. However, the combination of IGB and liraglutide seems to promote greater weight loss without increasing the occurrence of complications. Therefore, liraglutide proved to be a good adjuvant drug for IGB therapy.

 

Keywords: Bariatric Endoscopy; Intragastric Balloon; Obesity; Bariatric Surgery

References

  1. Leeman MF., et al. “The intra-gastric balloon for pre-operative weight loss in bariatric surgery: is it worthwhile?” Obesity Surgery8 (2013): 1262-1265.
  2. Frutos MD., et al. “Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass”. Obesity Surgery2 (2007): 150-154.
  3. Keren D and Rainis T. “Intragastric Balloons for Overweight Populations-1 Year Post Removal”. Obesity Surgery8 (2018): 2368-2373.
  4. Rahman AA and Loi K. “Gastric Perforation as a complication of intragastric balloon”. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery5 (2018): 719-722.
  5. Coffin B., et al. “Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study”. Obesity Surgery 4 (2017): 902-909.
  6. Lemaitre F., et al. “Laparoscopic sleeve gastrectomy in the South Pacific. Retrospective evaluation of 510 patients in a single institution”. International Journal of Surgery 30 (2016): 1-6.
  7. Fujishima Y., et al. “Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes”. Cardiovascular Diabetology 11 (2012): 107.
  8. Shyangdan DS., et al. “Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis”. BMC Endocrine Disorders 10 (2010): 20.
  9. Vilsboll T., et al. “Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials”. British Medical Journal 344 (2012): d7771.
  10. Torekov SS., et al. “Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential”. Obesity Reviews 8 (2011): 593-601.
  11. Nuffer WA and Trujillo JM. “Liraglutide: A New Option for the Treatment of Obesity”. Pharmacotherapy 10 (12015): 926-934.
  12. Wadden TA., et al. “Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study”. International Journal of Obesity 11 (2013): 1443-1451.
  13. Mosli M and Elyas M. “Does combining liraglutide with intragastric balloon insertion improve sustained weight reduction?” Saudi Journal of Gastroenterology2 (2017): 117-122.
  14. Matyjaszek-Matuszek B., et al. “Pharmacotherapy of obesity - state of the art”. Endokrynologia Polska4 (2018).
  15. Moura D., et al. “Effectiveness of intragastric balloon for obesity: A systematic review and meta-analysis based on randomized control trials”. Surgery for Obesity and Related Diseases 2 (2016): 420-429.
  16. Borges AC., et al. “Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience”. Revista do Colegio Brasileiro de Cirurgioes1 (2018): e1448.
  17. , Apollo Endosurgery. Orbera TM intragastric balloon system (Orbera TM). San Diego: Apollo Endosurgery (2015): 1-30.
  18. Abu Dayyeh BK. “Intragastric Balloons for Obesity Management”. Gastroenterology and Hepatology12 (2017): 737-739.
  19. Alsabah S., et al. “The safety and efficacy of the procedureless intragastric balloon”. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery3 (2018): 311-317.
  20. Tate CM and Geliebter A. “Intragastric Balloon Treatment for Obesity: FDA Safety Updates”. Advances in Therapy1 (2018): 1-4.
  21. Kumar N., et al. “The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-Analysis”. Obesity Surgery9 (2017): 2272-2278.
  22. Madsbad S. “The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications”. Diabetes, Obesity and Metabolism 1 (2014): 9-21.
  23. Secher A., et al. “The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss”. Journal of Clinical Investigation 10 (2014): 4473-4488.
  24. Khera R., et al. “Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis”. The Journal of the American Medical Association 22 (2016): 2424-2434.
  25. Wadden TA., et al. “Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial”. Obesity1 (2019): 75-86.
  26. Rye P., et al. “Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery”. Obesity Surgery 11 (2018): 3553-3558.
  27. Faria AM., et al. “[Recent progress and novel perspectives on obesity pharmacotherapy]”. Arquivos Brasileiros de Endocrinologia E Metabologia 6 (2010): 516-529.
  28. Ponce J., et al. “The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity”. Surgery for Obesity and Related Diseases 4 (2015): 874-881.
Citation: Anna Carolina Hoff., et al. “Combination of Intragastric Balloon and Liraglutide: Short-Term Results”. EC Gastroenterology and Digestive System 8.2 (2021): 124-131.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 28, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk